期刊文献+

Stanford A型主动脉夹层弓部置换体外循环术后延迟苏醒危险因素分析 被引量:3

Analysis of Risk Factors of Delayed Recovery after Bow Replacement Extracorporeal Circulation Operation for Patients with Stanford A Aortic Dissection
下载PDF
导出
摘要 目的:回顾性分析288例Stanford A型主动脉夹层患者在体外循环(CPB)下行弓部置换手术延迟苏醒的相关危险因素。方法:对所有病例用深低温停循环(DHCA)选择性顺行脑灌(SACP)治疗主动脉夹层弓部置换的临床资料进行分析,根据术后24h苏醒情况分为术后意识恢复正常组和术后延迟苏醒组,用Logistic回归分析术后发生延迟苏醒的独立危险因素。结果:SACP时间、术中最高乳酸值及术后白细胞(WBC)计数为患者术后延迟苏醒的独立危险因素。结论:Stanford A型主动脉夹层弓部置换术后延迟苏醒是多因素的共同结果,临床上应减少SACP时间,降低乳酸堆积及术后WBC。 Objective:To retrospectively analyze the risk factors of delayed recovery after bow replacement extracorporeal circulation operation for patients with Stanford A aortic dissection.Methods:The clinical data of all patients with aortic dissection bow replacement treated with deep hypothemic circulatory arrest(DHCA)and selective anterograde cerebral perfusion(SACP)was analyzed.All patients were divided into normal consciousness group and postoperative delayed awakening group according to the situation of postoperative 24 hours consciousness recovery.Then the independent risk factor of postoperative delayed recovery was analyzed by logistic regression model.Results:The SACP time,intraoperative highest lactic acid value,and Postoperative white blood cell(WBC)count were the independent risk factors of postoperative delayed awakening.Conclusion:Delayed recovery after bow replacement extracorporeal circulation operation for Stanford A aortic dissection is the result of multiple factors.It should shorten the SACP time,reduce the intraoperative lactic acid value and the postoperative WBC count to improve the symptoms.
出处 《数理医药学杂志》 2017年第4期494-496,共3页 Journal of Mathematical Medicine
关键词 主动脉弓部置换 选择性脑灌 延迟苏醒 危险因素 aortic arch replacement SACP delayed recovery risk factors
  • 相关文献

参考文献2

二级参考文献30

  • 1Maekawa K,Sudoh T,Fumsawa M,et al. Cloning and sequence a- nalysis o{ cDNA encoding a precursor for porcine brain natrinretic peptide[J]. Biochem Biophys Res Commun, 1988,157 (1):410 - ~16.
  • 2Asada J, Tsuji H, Thomas JD, et al. Usefulness of plasma brain natri- uretic peptide levels in predicting doubutamine - induced ischemia[J]. Am J Cardiol,2004,93(6)~ 702- 704.
  • 3Burley DS, Baxter GF. B - type natriuretie peptide limits reperfu- sion injury via opening of ATP -sensitive potassium channels[J]. J Mol Cell Cardiol,2006,40(6) :967 - 968.
  • 4Harold L, Lazar, Yusheng B, et al. Nesiritide enhances myocardial protection during the revascularization of acutely ischemic myocar- dium[J]. Cardiac Surgery,g009,24(5) :600 - 605.
  • 5Yiguo S, Yun Z, Ming Y, et al. B - Type natriuretic peptide induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition[J]. Biologieal~ Pharma-ceutical Bullietin,2009,32(9) :1545 - 1551.
  • 6Mekontso - Dessap A,Tual L,Kirsch M,et al. B - type natriuretic peptide to assess haemodynamic status after cardiac surgery[J]. British J Anaesthesia, 2006,97, (6) : 777 - 782.
  • 7Ozhan H, Albayrak S, Uzun H. Correlation of plasma B- Type na- triuretic peptide with shunt severity in patients with atrial or ven- tricular septal defectS[J]. Pediatric Cardiol,2007,28(4) :272 - 275.
  • 8Muta H, Ishii M, Maeno Y, et al. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide be- fore and after transcatheter closure of atrial septal defect[J]. Acta Paediatr,2002,91 (6) :649 -652.
  • 9Robert M, Mentzer, Mehrnet C, et al. Effects of perioptive siritide in patients with left ventricular dysfunction undergoing cardiac sor- ger[J]. J Am Coil Cardiol, 2007,49 : 716 - 726.
  • 10Moonesinghea SR, Mythenb MG. Groeottc MP,et al. Patient re lated risk factors for postoperative adverse events[J].Current Opinion Critieal Care, 2009,15 (4) : 320 - 327.

共引文献8

同被引文献37

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部